NCT00823693View on ClinicalTrials.gov

Safety and Efficacy Study of Bimosiamose Cream to Treat Psoriasis

PHASE2CompletedINTERVENTIONAL

Enrollment

107

Participants

Timeline

Start Date

Not specified

Conditions

Psoriasis

Interventions

DRUG

Bimosiamose Cream

DRUG

Placebo Cream

Trial Locations (1)

Unknown

Charité Campus Mitte, Klinik für Dermatologie, Venerologie und Allergologie, Berlin

All Listed Sponsors

lead

Revotar Biopharmaceuticals AG

INDUSTRY